Preparation of a compressed membrane containing immobilized biologically acting material

• US 5,283,186 A
• Filed: 12/31/1991
• Issued: 02/01/1994
• Est. Priority Date: 12/31/1991
• Status: Expired due to Term

• Current Assignee: Hospira Incorporated (Pfizer Inc.)
• Original Assignee: Abbott Laboratories Incorporated
• Inventors: Cunningham, David D., Johnson, Kenneth S.
• Primary Examiner(s): Naff, David M.
• Application Number:
  US07/815,422
• Time in Patent Office: 763 Days
• Field of Search: 435/177, 435/180, 435/182, 436/531, 436/535, 530/815, 530/817
• US Class Current: 435/180
• CPC Class Codes: C12N 11/04 entrapped within the carrier, e.g. gel or hollow fibres
• CPC Class Codes: C12N 11/082 obtained by reactions only involving carbon-to-carbon unsaturated bonds
• CPC Class Codes: Y10S 530/815 Carrier is a synthetic polymer
• CPC Class Codes: Y10S 530/817 Entrapped within the carrier, e.g. gel, hollow fibre

Abstract

A porous carrier containing an immobilized biologically active material is prepared in which a relatively large amount of an enzyme or an antibody has been immobilized in a manner that produces a low diffusion resistance toward reagents and products. The porous carrier is produced by fixing enzymes or antibodies within internal micropores of the carrier and mechanically compressing the carrier to a final thickness which is in the range of about 0.20 to 0.80 times the uncompressed carrier thickness. The compressed carrier may have a density about 1.25 to about 5.0 times the density of the carrier before compressing. Surprisingly, the compressed carrier exhibits less diffusion resistance to specific reagents and products than would an uncompressed carrier. A preferred porous carrier is a semi-permeable membrane made from synthetic polymers, such as polyvinylidine difluoride.

Claims

1. A process for making a porous carrier containing an immobilized protein, which comprises:

attaching a plurality of polar functional groups to an internal surface which defines a plurality of micropores distributed throughout a porous membrane substrate so that the substrate is about 30 to about 80 volume percent porous;

covalently bonding a plurality of selective proteins to at least a portion of the functional groups; and

physically compressing the membrane substrate to produce an irreversibly compressed membrane substrate having a pore size of at least about 0.01 micron, a porosity of about 10 to about 50 volume percent, a density of about 1.25 to about 5.0 times the density of the membrane substrate before compressing and a thickness of about 0.2 to about 0.8 times the thickness of the membrane substrate before the compressing.

2. The process of claim 1 wherein the membrane substrate comprises polyvinylidine difluoride.

3. The process of claim 1 wherein the protein is immobilized throughout the membrane substrate in a substantially uniform distribution.

4. The process of claim 1 wherein the protein is glucose oxidase.

5. The process of claim 1 wherein the protein is urease.

6. The process of claim 1 wherein the protein is creatinine deiminase.

7. The process of claim 1 wherein the protein is an antibody.

8. A porous carrier containing an immobilized protein prepared by the process of claim 1.

9. The process of claim 8 wherein the membrane substrate comprises polyvinylidine difluoride.

10. The process of claim 1 wherein the protein is immobilized throughout the membrane substrate in a substantially uniform distribution.

11. The process of claim 8 wherein the protein is an antibody.

12. The process of claim 8 wherein the protein is glucose oxidase.

13. The process of claim 8 wherein the protein is urease.

14. The process of claim 8 wherein the protein is creatinine deiminase.